Tushar H More1,2, Ravindra Taware1, Khushman Taunk1, Venkatesh Chanukuppa1,2, Venkateshwarlu Naik1, Anupama Mane3, Srikanth Rapole4. 1. Proteomics Lab, National Centre for Cell Science, Ganeshkhind, Pune, 411007, MH, India. 2. Savitribai Phule Pune University, Ganeshkhind, Pune, 411007, MH, India. 3. Grant Medical Foundation, Ruby Hall Clinic, Pune, 411001, MH, India. 4. Proteomics Lab, National Centre for Cell Science, Ganeshkhind, Pune, 411007, MH, India. rsrikanth@nccs.res.in.
Abstract
INTRODUCTION: Invasive ductal carcinoma (IDC) is a type of breast cancer, usually detected in advanced stages due to its asymptomatic nature which ultimately leads to low survival rate. Identification of urinary metabolic adaptations induced by IDC to understand the disease pathophysiology and monitor therapy response would be a helpful approach in clinical settings. Moreover, its non-invasive and cost effective strategy better suited to minimize apprehension among high risk population. OBJECTIVE: This study aims toward investigating the urinary metabolic alterations of IDC by targeted (LC-MRM/MS) and untargeted (GC-MS) approaches for the better understanding of the disease pathophysiology and monitoring therapy response. METHODS: Urinary metabolic alterations of IDC subjects (63) and control subjects (63) were explored by targeted (LC-MRM/MS) and untargeted (GC-MS) approaches. IDC specific urinary metabolomics signature was extracted by applying both univariate and multivariate statistical tools. RESULTS: Statistical analysis identified 39 urinary metabolites with the highest contribution to metabolomic alterations specific to IDC. Out of which, 19 metabolites were identified from targeted LC-MRM/MS analysis, while 20 were identified from the untargeted GC-MS analysis. Receiver operator characteristic (ROC) curve analysis evidenced 6 most discriminatory metabolites from each type of approach that could differentiate between IDC subjects and controls with higher sensitivity and specificity. Furthermore, metabolic pathway analysis depicted several dysregulated pathways in IDC including sugar, amino acid, nucleotide metabolism, TCA cycle etc. CONCLUSIONS: Overall, this study provides valuable inputs regarding altered urinary metabolites which improved our knowledge on urinary metabolomic alterations induced by IDC. Moreover, this study identified several dysregulated metabolic pathways which offer further insight into the disease pathophysiology.
INTRODUCTION:Invasive ductal carcinoma (IDC) is a type of breast cancer, usually detected in advanced stages due to its asymptomatic nature which ultimately leads to low survival rate. Identification of urinary metabolic adaptations induced by IDC to understand the disease pathophysiology and monitor therapy response would be a helpful approach in clinical settings. Moreover, its non-invasive and cost effective strategy better suited to minimize apprehension among high risk population. OBJECTIVE: This study aims toward investigating the urinary metabolic alterations of IDC by targeted (LC-MRM/MS) and untargeted (GC-MS) approaches for the better understanding of the disease pathophysiology and monitoring therapy response. METHODS: Urinary metabolic alterations of IDC subjects (63) and control subjects (63) were explored by targeted (LC-MRM/MS) and untargeted (GC-MS) approaches. IDC specific urinary metabolomics signature was extracted by applying both univariate and multivariate statistical tools. RESULTS: Statistical analysis identified 39 urinary metabolites with the highest contribution to metabolomic alterations specific to IDC. Out of which, 19 metabolites were identified from targeted LC-MRM/MS analysis, while 20 were identified from the untargeted GC-MS analysis. Receiver operator characteristic (ROC) curve analysis evidenced 6 most discriminatory metabolites from each type of approach that could differentiate between IDC subjects and controls with higher sensitivity and specificity. Furthermore, metabolic pathway analysis depicted several dysregulated pathways in IDC including sugar, amino acid, nucleotide metabolism, TCA cycle etc. CONCLUSIONS: Overall, this study provides valuable inputs regarding altered urinary metabolites which improved our knowledge on urinary metabolomic alterations induced by IDC. Moreover, this study identified several dysregulated metabolic pathways which offer further insight into the disease pathophysiology.
Entities:
Keywords:
Breast cancer; GC–MS; Invasive ductal carcinoma; LC-MRM/MS; Metabolomics; Urine
Authors: Mohit Jain; Roland Nilsson; Sonia Sharma; Nikhil Madhusudhan; Toshimori Kitami; Amanda L Souza; Ran Kafri; Marc W Kirschner; Clary B Clish; Vamsi K Mootha Journal: Science Date: 2012-05-25 Impact factor: 47.728
Authors: L D Kellenberger; J E Bruin; J Greenaway; N E Campbell; R A Moorehead; A C Holloway; J Petrik Journal: J Oncol Date: 2010-02-17 Impact factor: 4.375
Authors: Brock C Christensen; Ashley A Smith; Shichun Zheng; Devin C Koestler; E Andres Houseman; Carmen J Marsit; Joseph L Wiemels; Heather H Nelson; Margaret R Karagas; Margaret R Wrensch; Karl T Kelsey; John K Wiencke Journal: J Natl Cancer Inst Date: 2010-12-16 Impact factor: 13.506
Authors: Matthew D Hirschey; Ralph J DeBerardinis; Anna Mae E Diehl; Janice E Drew; Christian Frezza; Michelle F Green; Lee W Jones; Young H Ko; Anne Le; Michael A Lea; Jason W Locasale; Valter D Longo; Costas A Lyssiotis; Eoin McDonnell; Mahya Mehrmohamadi; Gregory Michelotti; Vinayak Muralidhar; Michael P Murphy; Peter L Pedersen; Brad Poore; Lizzia Raffaghello; Jeffrey C Rathmell; Sharanya Sivanand; Matthew G Vander Heiden; Kathryn E Wellen Journal: Semin Cancer Biol Date: 2015-10-08 Impact factor: 15.707
Authors: Håvard Søiland; Emiel A M Janssen; Thomas Helland; Finn Magnus Eliassen; Magnus Hagland; Oddmund Nordgård; Siri Lunde; Tone Hoel Lende; Jørn Vegard Sagen; Kjersti Tjensvoll; Bjørnar Gilje; Kristin Jonsdottir; Einar Gudlaugsson; Kirsten Lode; Kari Britt Hagen; Birgitta Haga Gripsrud; Ragna Lind; Anette Heie; Turid Aas; Marie Austdal; Nina Gran Egeland; Tomm Bernklev; Timothy L Lash; Linn Skartveit; Ann Cathrine Kroksveen; Satu Oltedal; Jan Terje Kvaløy; Ernst A Lien; Linda Sleire; Gunnar Mellgren Journal: BMJ Open Date: 2022-04-29 Impact factor: 3.006